» Articles » PMID: 25152897

Glycyrrhizin Attenuates Toll Like Receptor-2, -4 and Experimental Vasospasm in a Rat Model

Overview
Journal J Immunol Res
Publisher Wiley
Date 2014 Aug 26
PMID 25152897
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Upregulated TLRs are observed in the serum of animals following experimental subarachnoid hemorrhage. This study was to examine glycyrrhizin's effect on proinflammatory cytokines and TLRs in SAH rats. Administration with glycyrrhizin was initiated 24 hr before and 1 hr later using osmotic minipump. Basilar arteries were harvested to examine TLRs mRNA and protein (rt-PCR and western blot) and CSF cytokines (rt-PCR). Morphologically, deformed endothelium, tortuous elastic lamina, and smooth muscle necrosis were observed in the SAH rats, but were absent in the glycyrrhizin pretreatment group. The TLR-3 protein level was not increased in SAH animals, compared with the controls, while that of TLR-2 and -4 in the SAH only and SAH plus vehicle groups was significantly elevated (P < 0.01). Pretreatment and treatment with glycyrrhizin reduced TLR-2 and -4 by 28 ± 8% and 33.4 ± 9.2%, respectively. Likewise, glycyrrhizin was able to reduce the IL-1β and MCP-1 mRNA levels. This study shows glycyrrhizin exerts anti-inflammatory effects on SAH induced vasospasm and attenuates the ultrashort time expression of TLRs, like TLR-2 and -4. It corresponds to SAH induced early brain injury. These findings offer credit to the antivasospastic effect of glycyrrhizin and its effect on SAH induced early brain injury.

Citing Articles

Transcriptome Analysis of Microglia Reveals That the TLR2/IRF7 Signaling Axis Mediates Neuroinflammation After Subarachnoid Hemorrhage.

Xu S, Mei S, Lu J, Wu H, Dong X, Shi L Front Aging Neurosci. 2021; 13:645649.

PMID: 34276335 PMC: 8278202. DOI: 10.3389/fnagi.2021.645649.


Effects of Glycyrrhizin Treatment on Diabetic Cornea.

Somayajulu M, McClellan S, Pitchaikannu A, Bessert D, Liu L, Steinle J J Ocul Pharmacol Ther. 2020; 37(1):12-23.

PMID: 33347772 PMC: 7826441. DOI: 10.1089/jop.2020.0105.


Inflammatory Pathways Following Subarachnoid Hemorrhage.

Khey K, Huard A, Mahmoud S Cell Mol Neurobiol. 2019; 40(5):675-693.

PMID: 31808009 PMC: 11448815. DOI: 10.1007/s10571-019-00767-4.


Glycyrrhizin Ameliorate Ischemia Reperfusion Lung Injury through Downregulate TLR2 Signaling Cascade in Alveolar Macrophages.

Fei L, Jifeng F, Tiantian W, Yi H, Linghui P Front Pharmacol. 2017; 8:389.

PMID: 28670282 PMC: 5472719. DOI: 10.3389/fphar.2017.00389.


Effects of Toll-Like Receptor 4 Antagonists Against Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in Mice.

Kawakita F, Fujimoto M, Liu L, Nakano F, Nakatsuka Y, Suzuki H Mol Neurobiol. 2016; 54(8):6624-6633.

PMID: 27738873 DOI: 10.1007/s12035-016-0178-7.

References
1.
Fujisawa Y, Sakamoto M, Matsushita M, Fujita T, Nishioka K . Glycyrrhizin inhibits the lytic pathway of complement--possible mechanism of its anti-inflammatory effect on liver cells in viral hepatitis. Microbiol Immunol. 2000; 44(9):799-804. DOI: 10.1111/j.1348-0421.2000.tb02566.x. View

2.
Murakami K, Koide M, Dumont T, Russell S, Tranmer B, Wellman G . Subarachnoid Hemorrhage Induces Gliosis and Increased Expression of the Pro-inflammatory Cytokine High Mobility Group Box 1 Protein. Transl Stroke Res. 2011; 2(1):72-9. PMC: 3072171. DOI: 10.1007/s12975-010-0052-2. View

3.
Kolias A, Sen J, Belli A . Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. J Neurosci Res. 2008; 87(1):1-11. DOI: 10.1002/jnr.21823. View

4.
Ghosh T, Mickelson D, Fink J, Solberg J, Inglefield J, Hook D . Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses. Cell Immunol. 2007; 243(1):48-57. DOI: 10.1016/j.cellimm.2006.12.002. View

5.
Ogiku M, Kono H, Hara M, Tsuchiya M, Fujii H . Glycyrrhizin prevents liver injury by inhibition of high-mobility group box 1 production by Kupffer cells after ischemia-reperfusion in rats. J Pharmacol Exp Ther. 2011; 339(1):93-8. DOI: 10.1124/jpet.111.182592. View